STAT+: Pfizer’s Lyme vaccine results set up tricky regulatory path

New results on Pfizer's Lyme disease vaccine, how the Middle East conflict could strain drug supply chains, and more biotech news in today's Readout newsletter.
Source
Stat News
Opens original article in a new tab


